Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 2Pain 1Osteoporosis 1Arthralgia 1

Interventions

Zoledronic Acid 8Letrozole 7Risedronic Acid 6Vitamin D 4Absorptiometry, Photon 4Calcium 3Progesterone 2Hormone Replacement Therapy 2Cholecalciferol 2Calcium Carbonate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1Testosterone 1Spectrum Analysis 1Raloxifene Hydrochloride 1Progestins 1Linseed Oil 1Exercise Movement Techniques 1Estrogens, Conjugated (USP) 1Estrogens 1Estrogen Replacement Therapy 1Estradiol 1Diphosphonates 1Dietary Supplements 1Diet, Fat-Restricted 1Denosumab 1Calcium Gluconate 1Calcium Citrate 1Bone Density 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoporosis × Calcium Citrate × Breast × Clear all
NCT00354302 2020-04-02

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Canadian Cancer Trials Group

Phase 3 Completed
497 enrolled
Breast

Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡